NCT04484688View on ClinicalTrials.gov

Prestilol(Perindopril+Bisoprolol) in Therapy of Patients With Atrial Fibrilation

UnknownOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

December 1, 2021

Conditions

Patient Participation

Interventions

DRUG

perindopril-bisoprolol

outpatients with permanent atrial fibrillation and with preserved ejection fraction

Trial Locations (2)

Unknown

Aversi Clinic, Tbilisi

Aversi Clinic, Tbilisi

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Aversi Clinic

OTHER

NCT04484688 - Prestilol(Perindopril+Bisoprolol) in Therapy of Patients With Atrial Fibrilation | Biotech Hunter | Biotech Hunter